Iterum Therapeutics reported a gross margin of 94.87% and a net margin of -2,302.31% for the quarter ended Sep 2025. These financial ratios cover 33 quarters of results from Sep 2017 through Sep 2025, standardized by Business Quant from the company’s SEC filings.
| Ratios | Sep2017 | Dec2017 | Mar2018 | Jun2018 | Sep2018 | Dec2018 | Mar2019 | Jun2019 | Sep2019 | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | |||||||||||||||||||||||||||||||||
| Gross Margin | 94.87% | ||||||||||||||||||||||||||||||||
| EBT Margin | -2,268.46% | ||||||||||||||||||||||||||||||||
| EBIT Margin | -1,982.31% | ||||||||||||||||||||||||||||||||
| EBITDA Margin | -1,982.31% | ||||||||||||||||||||||||||||||||
| Operating Margin | -1,982.31% | ||||||||||||||||||||||||||||||||
| Net Margin | -2,302.31% | ||||||||||||||||||||||||||||||||
| FCF Margin | -1,912.56% | ||||||||||||||||||||||||||||||||
| Efficiency | |||||||||||||||||||||||||||||||||
| Inventory AverageInventory Avg. | 0.74M | 1.05M | |||||||||||||||||||||||||||||||
| Assets AverageAssets Avg. | 29.53M | 73.98M | 110.61M | 102.23M | 94.97M | 87.79M | 80.38M | 74.12M | 69.19M | 62.48M | 54.57M | 45.37M | 32.99M | 22.94M | 16.90M | 15.05M | 30.26M | 38.78M | 33.49M | 33.26M | |||||||||||||
| Invested CapitalInvested Cap. | 7.14M | 72.91M | 79.24M | 71.01M | 64.85M | 60.80M | 54.01M | 42.46M | 38.29M | 30.02M | 18.95M | 15.97M | 5.05M | 6.05M | 2.04M | 2.20M | 10.38M | -2.55M | -3.89M | -7.38M | |||||||||||||
| Asset Utilization RatioAsset Util. | 0.01 | ||||||||||||||||||||||||||||||||
| Leverage & Solvency | |||||||||||||||||||||||||||||||||
| Interest Coverage RatioInterest Cover | -8.23 | -5.30 | -6.46 | -3.48 | -5.41 | -12.31 | -13.76 | ||||||||||||||||||||||||||
| Debt Ratio | 1.76 | 0.36 | 0.30 | 0.19 | 0.16 | 0.14 | 0.13 | 0.14 | 0.15 | 0.19 | 0.23 | 0.32 | 0.44 | 0.62 | 0.91 | 0.86 | 0.32 | ||||||||||||||||
| Times Interest Earned | -8.23 | -5.30 | -6.46 | -3.48 | -5.41 | -12.31 | -13.76 | ||||||||||||||||||||||||||
| Return Ratios | |||||||||||||||||||||||||||||||||
| Return on Sales [ROS]ROS | -1,982.31% | ||||||||||||||||||||||||||||||||
| Return on Capital Employed [ROCE]ROCE | 264.04% | -83.13% | -31.24% | -26.48% | -29.91% | -33.54% | -37.22% | -43.97% | -50.53% | -57.68% | -78.44% | -151.71% | -243.73% | -876.09% | -30,726.91% | 724.06% | -147.74% | -46.20% | -63.64% | -76.93% | |||||||||||||
| Return on Invested Capital [ROIC]ROIC | -1,110.35% | -59.65% | -29.52% | -27.77% | -31.61% | -133.98% | 6.98% | -44.27% | -65.85% | -81.77% | -125.31% | -208.53% | -397.70% | -706.52% | -787.88% | -1,053.55% | -260.57% | -359.10% | 483.37% | 325.30% | |||||||||||||
| Return on Assets [ROA]ROA | -154.25% | -173.53% | -97.69% | -90.10% | -83.72% | 18.13% | 1.72% | -42.45% | -55.81% | -72.04% | -92.56% | -55.72% | -105.42% | -139.45% | -146.44% | -179.17% | -72.17% | -50.60% | -63.11% | -72.23% |